We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-20.18%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.95B
AUM Growth
-$1.51B
Cap. Flow
-$541M
Cap. Flow %
-27.79%
Top 10 Hldgs %
66.18%
Holding
59
New
2
Increased
9
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
IVA
Inventiva
IVA
+$38.9M
2
SNTI icon
Senti Biosciences Holdings
SNTI
+$35.6M
3
TRVI icon
Trevi Therapeutics
TRVI
+$27.9M
4
PANW icon
Palo Alto Networks
PANW
+$17.4M
5
NKTX icon
Nkarta
NKTX
+$8.75M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$644M
2
IONQ icon
IonQ
IONQ
+$20.7M
3
GNCA
Genocea Biosciences, Inc.
GNCA
+$13M
4
ELVN icon
Enliven Therapeutics
ELVN
+$2.81M
5
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
+$818K

Sector Composition

Rank Sector Weight
1 Healthcare 69.32%
2 Technology 12.48%
3 Consumer Staples 11.56%
4 Industrials 4.58%
5 Communication Services 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLS
51
DELISTED
Regulus Therapeutics
RGLS
$2.99M 0.15%
1,445,115
– –
UP icon
52
Wheels Up
UP
$197M
$2.07M 0.11%
5,306
– –
ELVN icon
53
Enliven Therapeutics
ELVN
$4.42B
$1.23M 0.06%
251,681
-575,342
-70% -$2.81M
ADXN
54
Addex Therapeutics
ADXN
$7.34M
$1.08M 0.06%
47,072
+38,072
+423% +$2.86M
TCON
55
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$693K 0.04%
17,336
– –
LUMO
56
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$503K 0.03%
65,374
-102,234
-61% -$818K
AKTX
57
Akari Therapeutics
AKTX
$14.1M
$452K 0.02%
565
– –
HOOD icon
58
Robinhood
HOOD
$81.6B
– –
-47,664,177
Closed -$644M
GNCA
59
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-10,376,936
Closed -$13M
1 2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

NEA Management Company's Q2 2022 Portfolio in Review

As of Q2 2022, NEA Management Company held 59 positions worth $1.95B, down 44% from $3.46B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

NEA Management Company withdrew a net $541M in Q2 2022, closing 2 positions and reducing 3 holdings. Its most notable exit was Robinhood, an estimated $644M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, NEA Management Company opened a new position in Senti Biosciences Holdings worth $7.46M.

  • NEA Management Company's largest Q2 2022 buy was Senti Biosciences Holdings: 442,973 shares worth $7.46M.
  • NEA Management Company added most to Inventiva in Q2 2022, an estimated $38.9M increase.
  • NEA Management Company's biggest Q2 2022 reduction was IonQ, cutting an estimated $20.7M.
  • NEA Management Company fully exited Robinhood in Q2 2022, selling an estimated $644M.
  • NEA Management Company's ten largest holdings make up 66% of its $1.95B portfolio in Q2 2022.
  • NEA Management Company opened 2 new positions and closed 2 in Q2 2022.
  • NEA Management Company's portfolio value fell 44% quarter-over-quarter to $1.95B.

Based on NEA Management Company's 13F filing for Q2 2022, filed 15 Aug 2022.